Opus Genetics (IRD) Non-Current Assets (2021 - 2023)
Opus Genetics (IRD) has disclosed Non-Current Assets for 8 consecutive years, with $3000.0 as the latest value for Q3 2023.
- On a quarterly basis, Non-Current Assets fell 57.14% to $3000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $18000.0, a 47.06% decrease, with the full-year FY2022 number at $6000.0, down 40.0% from a year prior.
- Non-Current Assets was $3000.0 for Q3 2023 at Opus Genetics, down from $4000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $13000.0 in Q1 2021 to a low of $3000.0 in Q3 2023.
- A 3-year average of $8000.0 and a median of $8000.0 in 2022 define the central range for Non-Current Assets.
- Peak YoY movement for Non-Current Assets: crashed 30.77% in 2022, then plummeted 57.14% in 2023.
- Opus Genetics' Non-Current Assets stood at $10000.0 in 2021, then crashed by 40.0% to $6000.0 in 2022, then plummeted by 50.0% to $3000.0 in 2023.
- Per Business Quant, the three most recent readings for IRD's Non-Current Assets are $3000.0 (Q3 2023), $4000.0 (Q2 2023), and $5000.0 (Q1 2023).